At BrandMed, we have termed the relationship between Inflammation,Autonomic Dysregulation, and Hormonal Imbalance, the INFLANOME™. And we constantly reimagine new ways to measure the INFLANOME™ for improved health and well-being.
UNDERSTANDING THE INFLANOME™
SYMPATHETIC OVERDRIVE
Nuno Vaz Dos Ramos
Chief Technology Officer at BrandMed
Oversees the development of a comprehensive risk and disease management platform for patients with Hypertension, Diabetes, Asthma and COPD. Awarded 2014 Innovation Prize by Microsoft and the Israeli Trade Commission for the design of a hospital readmission programme using wearable devices